ArticleJournal of managed care & specialty pharmacy2025

Health care resource utilization and costs of Medicare-enrolled patients with HR+/HER2- metastatic breast cancer treated with a CDK4/6i in the first-line setting.

Emma Behan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.